See the 2010 TREATMENT GUIDELINES for the most recent treatment information.
Terms and Abbreviations Used in This Report
Previous Page Next Page: Consultants
| AIDS | Acquired immunodeficiency syndrome |
| ALT | Alanine aminotransferase |
| anti-HBc | Antibody to hepatitis B core antigen |
| anti-HCV | Hepatitis C antibodies |
| ASC-US | Atypical squamous cells of undetermined significance |
| BCA | Bichloroacetic acid |
| BV | Bacterial vaginosis |
| CBC | Complete blood count |
| CI | Confidence interval |
| CIN | Cervical intraepithelial neoplasia |
| CLIA | Clinical Laboratory Improvement Amendments |
| CNS | Central nervous system |
| CI | Confidence interval |
| CSF | Cerebrospinal fluid |
| DFA | Direct fluorescent antibody |
| DGI | Disseminated gonococcal infection |
| dL | Deciliter |
| DNA | Deoxyribonucleic acid |
| EC | Emergency contraception |
| EIA | Enzyme immunoassay |
| ELISA | Enzyme-linked immunosorbent assay |
| EPT | Expedited partner therapy |
| FDA | Food and Drug Administration |
| FTA-ABS | Fluorescent treponemal antibody absorbed |
| gG | Glycoprotein G |
| GNID | Gram-negative intracellular diplococci |
| HAART | Highly active antiretroviral therapy |
| HAV | Hepatitis A virus |
| HBIG | Hepatitis B immune globulin |
| HBsAg | Hepatitis B surface antigen |
| HBV | Hepatitis B virus |
| HCC | hepatocellular carcinoma |
| HCV | Hepatitis C virus |
| HIV | Human immunodeficiency virus |
| HPV | Human papillomavirus |
| HSV | Herpes simplex virus |
| IFA | Immunofluorescence assay |
| IgE | Immunoglobulin E |
| Ig | Immune globulin |
| IgG | Immunoglobulin G |
| IgM | Immunoglobulin |
| IM | Intramuscularly |
| IUD | Intrauterine device |
| IV | Intravenous or intravenously |
| KOH | Potassium hydroxide |
| LGV | Lymphogranuloma venereum |
| MAC | Mycobacterium avium complex |
| MIC | Minimum inhibitory concentration |
| MSM | Men who have sex with men |
| N-9 | Nonoxynol-9 |
| NAAT | Nucleic acid amplification test |
| NGU | Nongonococcal urethritis |
| Pap | Papanicolaou |
| PCR | Polymerase chain reaction |
| PEP | Postexposure prophylaxis |
| PID | Pelvic inflammatory disease |
| PO | By mouth |
| PPV | Positive predictive value |
| QRNG | Quinolone resistant Neisseria gonorrhoeae |
| RNA | Ribonucleic acid |
| RPR | Rapid plasma reagin |
| RT-PCR | Reverse transcriptase polymerase chain reaction |
| RVVC | Recurrent vulvovaginal candidiasis |
| SIL | Squamous intraepithelial lesion |
| STD | Sexually transmitted disease |
| TCA | Trichloroacetic acid |
| TE | Toxoplasmic encephalitis |
| TP-PA | Treponema pallidum particle agglutation |
| VDRL | Venereal Disease Research Laboratory |
| VVC | Vulvovaginal candidiasis |
| WB | Western blot |
| WBC | White blood count |
| WSW | Women who have sex with women |
Previous Page Next Page: Consultants
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO
